Cargando…

Second-Generation Antipsychotics and Extrapyramidal Adverse Effects

Antipsychotic-induced extrapyramidal adverse effects are well recognized in the context of first-generation antipsychotic drugs. However, the introduction of second-generation antipsychotics, with atypical mechanism of action, especially lower dopamine receptors affinity, was met with great expectat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Divac, Nevena, Prostran, Milica, Jakovcevski, Igor, Cerovac, Natasa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065707/ https://www.ncbi.nlm.nih.gov/pubmed/24995318 http://dx.doi.org/10.1155/2014/656370

Ejemplares similares

The Efficacy and Safety of Antipsychotic Medications in the Treatment of Psychosis in Patients with Parkinson's Disease
por: Divac, Nevena, et al.
Publicado: (2016)

Pharmacotherapy of Pain in the Older Population: The Place of Opioids
por: Prostran, Milica, et al.
Publicado: (2016)

Confocal Synaptology: Synaptic Rearrangements in Neurodegenerative Disorders and upon Nervous System Injury
por: Vulovic, Maja, et al.
Publicado: (2018)

Maternal Deprivation in Rats Decreases the Expression of Interneuron Markers in the Neocortex and Hippocampus
por: Aksic, Milan, et al.
Publicado: (2021)

A retrospective study of extrapyramidal syndromes with second generation antipsychotics in the psychiatric unit of a tertiary care teaching hospital
por: Lahon, Kingshuk, et al.
Publicado: (2012)

Improving pharmacogenetic prediction of extrapyramidal symptoms induced by antipsychotics
por: Boloc, Daniel, et al.
Publicado: (2018)

Thermomineral water promotes axonal sprouting but does not reduce glial scar formation in a mouse model of spinal cord injury
por: Aleksić, Dubravka, et al.
Publicado: (2014)

Current and Novel Approaches to Mitigate Cardiometabolic Adverse Effects of Second-Generation Antipsychotics
por: Skonieczna-Żydecka, Karolina, et al.
Publicado: (2020)

Possible sertraline-induced extrapyramidal adverse effects in an adolescent
por: Wang, Lian-fang, et al.
Publicado: (2016)

Author Correction: Improving pharmacogenetic prediction of extrapyramidal symptoms induced by antipsychotics
por: Boloc, Daniel, et al.
Publicado: (2019)

ANTIPSYCHOTIC-INDUCED VACUOUS CHEWING MOVEMENTS AND EXTRAPYRAMIDAL SIDE-EFFECTS ARE HIGHLY HERITABLE IN MICE
por: Crowley, James J., et al.
Publicado: (2010)

Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine D(2) receptors
por: Sykes, David A., et al.
Publicado: (2017)

Antipsychotic Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD): Management of Extrapyramidal Side Effects
por: Ohno, Yukihiro, et al.
Publicado: (2019)

Exercise and Worsening of Extrapyramidal Symptoms during Treatment with Long-Acting Injectable Antipsychotics
por: Kim, David D., et al.
Publicado: (2021)

Antipsychotic-induced extrapyramidal side effects: A systematic review and meta-analysis of observational studies
por: Ali, Tilahun, et al.
Publicado: (2021)

Antipsychotics with similar association kinetics at dopamine D(2) receptors differ in extrapyramidal side-effects
por: Zeberg, Hugo, et al.
Publicado: (2018)

Study on risk factors of extrapyramidal symptoms induced by antipsychotics and its correlation with symptoms of schizophrenia
por: Weng, Jiajun, et al.
Publicado: (2019)

Reply to ‘Antipsychotics with similar association kinetics at dopamine D(2) receptors differ in extrapyramidal side-effects’
por: Sykes, David A., et al.
Publicado: (2018)

Pioglitazone attenuates kidney injury in an experimental model of gentamicin-induced nephrotoxicity in rats
por: Medić, Branislava, et al.
Publicado: (2019)

Antioxidant Properties of Second-Generation Antipsychotics: Focus on Microglia
por: Caruso, Giuseppe, et al.
Publicado: (2020)

Antipsychotic dose, dopamine D2 receptor occupancy and extrapyramidal side-effects: a systematic review and dose-response meta-analysis
por: Siafis, Spyridon, et al.
Publicado: (2023)

Second-generation antipsychotics and metabolism alterations: a systematic review of the role of the gut microbiome
por: Skonieczna-Żydecka, Karolina, et al.
Publicado: (2018)

Second Generation Antipsychotics in the Treatment of Major Depressive Disorder: An Update
por: Wang, Sheng-Min, et al.
Publicado: (2016)

Differentiating Between Lithium Tremors and Extrapyramidal Tremors in a Patient on Long-Term Antipsychotics and Lithium Medication
por: Singh, Gurraj, et al.
Publicado: (2023)

Updating the Comparative Evidence on Second‐Generation Antipsychotic Use With Schizophrenia
por: McDonagh, Marian S., et al.
Publicado: (2020)

Second-Generation Antipsychotic Discontinuation in First Episode Psychosis: An Updated Review
por: Miller, Brian J., et al.
Publicado: (2011)

Controversies in bipolar disorder; role of second-generation antipsychotic for maintenance therapy
por: Jauhar, Sameer, et al.
Publicado: (2019)

Integrative Management of Metabolic Syndrome in Youth Prescribed Second-Generation Antipsychotics
por: Rice, Jessie, et al.
Publicado: (2020)

Second-Generation Antipsychotics and Dysregulation of Glucose Metabolism: Beyond Weight Gain
por: Grajales, Diana, et al.
Publicado: (2019)

Pharmacogenetics and Schizophrenia—Can Genomics Improve the Treatment with Second-Generation Antipsychotics?
por: Płaza, Olga, et al.
Publicado: (2022)

Relating Spontaneously Reported Extrapyramidal Adverse Events to Movement Disorder Rating Scales
por: Widschwendter, Christian G., et al.
Publicado: (2015)

Akathisia as an Extrapyramidal Side Effect of Fluoxetine
por: Ajufo, Ijeoma, et al.
Publicado: (2021)

Drug-Induced Extrapyramidal Syndromes
por: Lader, M. H.
Publicado: (1970)

Association Between Serotonin Syndrome and Second‐Generation Antipsychotics via Pharmacological Target‐Adverse Event Analysis
por: Racz, Rebecca, et al.
Publicado: (2018)

Arterial Stiffness in Patients Taking Second-generation Antipsychotics
por: Fındıklı, Ebru, et al.
Publicado: (2016)

Metabolic consequences of second-generation antipsychotics in youth: appropriate monitoring and clinical management
por: Krill, Rebecca A, et al.
Publicado: (2014)

Effectiveness of second generation antipsychotics: A systematic review of randomized trials
por: Johnsen, Erik, et al.
Publicado: (2008)

Escitalopram-induced extrapyramidal symptoms
por: Kumar, Pattath Narayanan Suresh, et al.
Publicado: (2019)

Critical Review of the Use of Second-Generation Antipsychotics in Obsessive–Compulsive and Related Disorders
por: Kim, Dongmi, et al.
Publicado: (2018)

Cariprazine as a useful treatment for patients with schizophrenia and antipsychotic-induced extrapyramidal symptoms: a case report and literature review
por: Llach, C., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bkfefnouv5h5t4ipe3e9ht28i5